Teva Pharmaceutical Industries Ltd (NYSE:TEVA)

64.41
Delayed Data
As of Apr 24
 +1.16 / +1.83%
Today’s Change
47.36
Today|||52-Week Range
68.75
+12.00%
Year-to-Date

Today’s Trading

Previous close63.25
Today’s open63.17
Day’s range62.80 - 64.52
Volume8,786,956
Average volume (3 months)5,570,507
Market cap$60.7B
Dividend yield2.10%
Data as of 4:04pm ET, 04/24/2015

Growth & Valuation

Earnings growth (last year)+136.23%
Earnings growth (this year)+1.34%
Earnings growth (next 5 years)+0.70%
Revenue growth (last year)-1.87%
P/E ratio18.1
Price/Sales2.45
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
DEPODepomed Inc+0.36+1.30%
NEPTNeptune Technologies...-0.01-0.57%
VBLTVascular Biogenics L...+0.07+1.68%
Data as of 4:00pm ET, 04/24/2015

Financials

Next reporting dateApril 30, 2015
EPS forecast (this quarter)$1.25
Annual revenue (last year)$20.0B
Annual profit (last year)$3.0B
Net profit margin15.07%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
President, Chief Executive Officer &
Director
Erez Vigodman
President &
CEO-Global Operations
Carlo de Notaristefani
Corporate headquarters
Petach Tikva, --

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers